OrthoPediatrics (NASDAQ:KIDS) Hits New 52-Week Low - Time to Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) hit a new 52-week low on Tuesday . The stock traded as low as $19.52 and last traded at $20.62, with a volume of 158156 shares traded. The stock had previously closed at $19.96.

Analyst Ratings Changes

A number of equities research analysts have issued reports on KIDS shares. Lake Street Capital assumed coverage on OrthoPediatrics in a research report on Monday, April 7th. They set a "buy" rating and a $37.00 price objective on the stock. Truist Financial lowered their price target on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Stifel Nicolaus cut their price objective on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research report on Wednesday, March 5th. Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Thursday, May 8th. Finally, Wall Street Zen downgraded shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a report on Friday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $35.83.

OrthoPediatrics Stock Performance

The firm has a market capitalization of $514.64 million, a P/E ratio of -17.23 and a beta of 1.08. The firm has a 50-day moving average price of $21.66 and a two-hundred day moving average price of $23.47. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). The company had revenue of $52.41 million for the quarter, compared to the consensus estimate of $51.68 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. On average, analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In other OrthoPediatrics news, insider Gregory A. Odle sold 5,359 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the sale, the insider now owns 148,788 shares in the company, valued at approximately $3,698,869.68. The trade was a 3.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David R. Bailey sold 6,620 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $164,573.20. Following the completion of the transaction, the chief executive officer now owns 319,155 shares in the company, valued at approximately $7,934,193.30. This trade represents a 2.03% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 23,732 shares of company stock worth $589,978. 32.70% of the stock is owned by insiders.

Hedge Funds Weigh In On OrthoPediatrics

Several institutional investors have recently made changes to their positions in the company. Millennium Management LLC purchased a new stake in OrthoPediatrics during the fourth quarter worth $9,798,000. Point72 Asset Management L.P. acquired a new position in shares of OrthoPediatrics in the fourth quarter worth about $7,450,000. Wasatch Advisors LP boosted its stake in shares of OrthoPediatrics by 47.2% during the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company's stock worth $16,141,000 after acquiring an additional 223,217 shares in the last quarter. Wellington Management Group LLP grew its position in shares of OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock valued at $24,601,000 after acquiring an additional 178,078 shares during the period. Finally, Paradigm Capital Management Inc. NY grew its position in shares of OrthoPediatrics by 1,607.0% during the 1st quarter. Paradigm Capital Management Inc. NY now owns 170,700 shares of the company's stock valued at $4,204,000 after acquiring an additional 160,700 shares during the period. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.